Form 8-K - Current report:
SEC Accession No. 0001062822-25-000019
Filing Date
2025-03-28
Accepted
2025-03-28 07:59:25
Documents
19
Period of Report
2025-03-27
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K lxrx-20250327.htm   iXBRL 8-K 33357
2 EX-10.1 exh101oxfordlexicon-seve.htm EX-10.1 32535
6 GRAPHIC exh101oxfordlexicon-seve001.jpg GRAPHIC 1023177
7 GRAPHIC exh101oxfordlexicon-seve002.jpg GRAPHIC 754487
8 GRAPHIC exh101oxfordlexicon-seve003.jpg GRAPHIC 329816
9 GRAPHIC exh101oxfordlexicon-seve004.jpg GRAPHIC 359838
10 GRAPHIC exh101oxfordlexicon-seve005.jpg GRAPHIC 24762
  Complete submission text file 0001062822-25-000019.txt   3635233

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lxrx-20250327.xsd EX-101.SCH 1776
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lxrx-20250327_lab.xml EX-101.LAB 21629
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lxrx-20250327_pre.xml EX-101.PRE 12504
21 EXTRACTED XBRL INSTANCE DOCUMENT lxrx-20250327_htm.xml XML 2738
Mailing Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381
Business Address 2445 TECHNOLOGY FOREST BLVD. SUITE 1100 THE WOODLANDS TX 77381 2818633000
LEXICON PHARMACEUTICALS, INC. (Filer) CIK: 0001062822 (see all company filings)

EIN.: 760474169 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-30111 | Film No.: 25781529
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)